Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus
a University
of Oulu, Oulu, Finland: Department of Paediatrics, b Department of Clinical Chemistry
Correspondence to: Dr Tuija Löppönen, Department of Paediatrics, University of Oulu, Kajaanintie 52 A, FIN-90220 Oulu, Finland.
Accepted 25 March 1997
OBJECTIVE
Children with hydrocephalus are
characterised by slow linear growth in prepuberty, accelerated physical
maturation during puberty, and reduced final height. We aimed to study
the possible roles of growth hormone, insulin-like growth factor-I
(IGF-I), and IGF binding protein-3 (IGFBP-3) in this growth pattern.
STUDY DESIGN
One hundred and fourteen patients
with shunted hydrocephalus (62 males) aged 5 to 20 years, of whom 17 had spina bifida (six males), and 73 healthy controls (38 males) were
studied. Anthropometric measures, body mass index, and body fat mass
were assessed and the stage of puberty was determined. Serum growth
hormone and plasma IGF-I and IGFBP-3 concentrations were measured.
RESULTS
The patients comprised 44 (26 males) who were prepubertal and 70 (36 males) pubertal or postpubertal,
while 32 of the controls (19 males) were prepubertal and 41 (19 males)
pubertal or postpubertal. The prepubertal children with hydrocephalus
had lower IGF-I (p = 0.002) and IGFBP-3 concentrations (p< 0.001)
than the controls, and the pubertal children had four times lower basal
growth hormone concentrations (p< 0.001). There was a correlation
between height SD score and IGF-I levels in the total patientpopulation
(r = 0.23; p = 0.01). Peripheral IGF-I concentrations
peaked at pubertal stages 2-3 in the female patients and at stage 4 in
the controls. The prepubertal patients on antiepileptic treatment,
carbamazepine in most cases (73%), had higher IGF-I (p = 0.01) and
IGFBP-3 concentrations (p = 0.03) than those who had never been
treated with antiepileptic drugs, but still lower IGFBP-3 levels than
the controls (p = 0.01).
CONCLUSION
Based on these findings, it can be
concluded that reduced growth hormone secretion may contribute to the
pattern of slow linear growth and reduced final height observed in
these patients.
|
Key messages
|
© 1997 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Arikoski, P., Komulainen, J., Riikonen, P., Voutilainen, R., Knip, M., Kröger, H.
(1999). Alterations in Bone Turnover and Impaired Development of Bone Mineral Density in Newly Diagnosed Children with Cancer: A 1-Year Prospective Study. J. Clin. Endocrinol. Metab.
84: 3174-3181
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Prepubertal children with shunted hydrocephalus have reduced
circulating IGF-I and IGFBP-3 concentrations



